Zobrazeno 1 - 10
of 3 489
pro vyhledávání: '"Shahan Mamoor"'
Autor:
Sidinh Luc, Jialiang Huang, Jennifer L. McEldoon, Ece Somuncular, Dan Li, Claire Rhodes, Shahan Mamoor, Serena Hou, Jian Xu, Stuart H. Orkin
Publikováno v:
Cell Reports, Vol 16, Iss 12, Pp 3181-3194 (2016)
B cell CLL/lymphoma 11A (BCL11A) is a transcription factor and regulator of hemoglobin switching that has emerged as a promising therapeutic target for sickle cell disease and thalassemia. In the hematopoietic system, BCL11A is required for B lymphop
Externí odkaz:
https://doaj.org/article/f4352ddea809447e87cd65eb97af8621
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2e501f55f6a042f95796b763fa9f9c8
https://doi.org/10.31219/osf.io/tgch7
https://doi.org/10.31219/osf.io/tgch7
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::666cb8202b463b34b20f3eefc0760016
https://doi.org/10.31219/osf.io/5nc2r
https://doi.org/10.31219/osf.io/5nc2r
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd4477f6d0ba88fd861d5c8714d6a0d
https://doi.org/10.31219/osf.io/vgc4n
https://doi.org/10.31219/osf.io/vgc4n
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57fe06b831edeba1f3c69ab70e57830c
https://doi.org/10.31219/osf.io/rhjdn
https://doi.org/10.31219/osf.io/rhjdn
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34f348713e1deb0b128714eba99d024d
https://doi.org/10.31219/osf.io/vfdmb
https://doi.org/10.31219/osf.io/vfdmb
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31b3653b538827674ab22f8500a5a3c2
https://doi.org/10.31219/osf.io/ezkpr
https://doi.org/10.31219/osf.io/ezkpr
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53c1cd6ae683bae2358c7a963d8dbe75
https://doi.org/10.31219/osf.io/pn2td
https://doi.org/10.31219/osf.io/pn2td
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::156b506021d118a95069f6ed454a91fd
https://doi.org/10.31219/osf.io/y4jwq
https://doi.org/10.31219/osf.io/y4jwq
Autor:
Shahan Mamoor
Skin cancer is diagnosed in nearly 1.5 million patients each year (1). While patients with basal and squamous cell carcinomas are provided with 5-year survival rates at nearly 100% and 90%, respectively, patients diagnosed with cutaneous melanoma (me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c905167fddf60610ccca64f12b1843d9
https://doi.org/10.31219/osf.io/acdn8
https://doi.org/10.31219/osf.io/acdn8